amantadine has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 8 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A recent controlled clinical trial suggested a role for amantadine as a treatment for pathological gambling in patients with Parkinson disease (PD)." | 7.76 | Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. ( Lang, AE; Potenza, MN; Siderowf, AD; Sohr, M; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR, 2010) |
| "Amantadine was well tolerated." | 6.70 | Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities. ( Dourish, CT; King, BH; Snape, M; Wright, DM, 2001) |
| "A recent controlled clinical trial suggested a role for amantadine as a treatment for pathological gambling in patients with Parkinson disease (PD)." | 3.76 | Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. ( Lang, AE; Potenza, MN; Siderowf, AD; Sohr, M; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR, 2010) |
| "Amantadine was well tolerated." | 2.70 | Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities. ( Dourish, CT; King, BH; Snape, M; Wright, DM, 2001) |
| "In patients who had impulse control disorders at baseline (n = 119), high dopamine agonist dose was associated with the presence of disorders at follow-up." | 1.38 | Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. ( Joutsa, J; Kaasinen, V; Martikainen, K; Vahlberg, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Moegle, C | 1 |
| Grillon, A | 1 |
| Anheim, M | 1 |
| Lipsker, D | 1 |
| Velter, C | 1 |
| Wilson, L | 1 |
| Sheehan, J | 1 |
| Thorpe, M | 1 |
| Vonder Haar, C | 1 |
| Lam, FC | 1 |
| Adams, WK | 1 |
| Riparip, LK | 1 |
| Kaur, S | 1 |
| Muthukrishna, M | 1 |
| Rosi, S | 1 |
| Winstanley, CA | 1 |
| Weintraub, D | 1 |
| Sohr, M | 1 |
| Potenza, MN | 1 |
| Siderowf, AD | 1 |
| Stacy, M | 1 |
| Voon, V | 1 |
| Whetteckey, J | 1 |
| Wunderlich, GR | 1 |
| Lang, AE | 2 |
| Lee, JY | 1 |
| Kim, HJ | 1 |
| Jeon, BS | 1 |
| Walsh, RA | 1 |
| Joutsa, J | 1 |
| Martikainen, K | 1 |
| Vahlberg, T | 1 |
| Kaasinen, V | 1 |
| King, BH | 1 |
| Wright, DM | 1 |
| Snape, M | 1 |
| Dourish, CT | 1 |
1 trial available for amantadine and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities.
Topics: Aggression; Amantadine; Brain Diseases; Child; Child, Preschool; Developmental Disabilities; Disrupt | 2001 |
7 other studies available for amantadine and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease.
Topics: Amantadine; Apomorphine; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Do | 2020 |
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse C | 2013 |
Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Amantadine; Amphetamine; Animals; Atomoxetine Hydrochlo | 2016 |
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
Topics: Aged; Amantadine; Antiparkinson Agents; Cross-Sectional Studies; Disruptive, Impulse Control, and Co | 2010 |
Is pathological gambling in Parkinson's disease reduced by amantadine?
Topics: Aged; Amantadine; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; | 2011 |
Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine.
Topics: Amantadine; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans | 2012 |
Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
Topics: Aged; Amantadine; Antidepressive Agents; Antiparkinson Agents; Data Collection; Depression; Disease | 2012 |